ACTIVE SINCE: 2021
Bristol Myers Squibb Foundation: Cancer Disparities in the Era of COVID19
Improving early diagnosis of lung cancer and expedite access to providers at specialty cancer hospitals.
SGDS CONTRIBUTING TO:


PARTNERING WITH:
SEE ALL PARTNER ORGANIZATIONS
SEE ALL PARTNER ORGANIZATIONS
Pharma Company Foundation 1
Hospitals Health Facilities 1
Irmandade Santa Casa de Porto Alegre will integrate specialized health care in oncology with primary health care through two complementary digital health strategies: teleconsultation and patient navigation.
The overall goals of the project are to improve early diagnosis of lung cancer and expedite access to providers at specialty cancer hospitals.
Results and milestones
- Parameters for the digital platform “just miine” are complete
- Total of 68 primary care profressionals trained to follow and navigate patients using the digital platforms
- All screened patients, total of 49, were referred to access to care according to the clinical recommendation based on the tomography result and the needs presented
Geographic Reach
- Americas
Disease Area
- Non-communicable Diseases
SGDs the partnership contributes to
- 3.4: NCDs (including mental health)
- 3.8: Achieve universal health coverage
Partner organizations
Pharma Company Foundation
Bristol Myers Squibb Foundation
Hospitals Health Facilities
Irmandade Santa Casa de Porto Alegre
Geographic Reach
Americas
- Brazil
Disease Area
Non-communicable Diseases
- Cancer
- Lung Cancer